Maryland Oncology Hematology

Columbia, Maryland 21044

4 studies enrolling now · 13 studies all time

What they study most

Breast Cancer, Cancer, Colon Cancer, Colorectal Cancer, Colorectal Cancer (CRC), KEAP1 Gene Mutation, Leukemia, Myeloid, Acute, Metastatic Pancreatic Ductal Adenocarcinoma, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, NFE2L2 Gene Mutation

Studies at this site

• A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL) — Recruiting now
• Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma — Recruiting now
• Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer — Recruiting now
• A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX — Completed
• A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer — Completed
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• Development and Validation of Harbinger Health Test for Early Cancer Detection — Completed
• Connect® Myeloid Disease Registry — Stopped early
• A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer — Stopped early
• Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2 — Stopped early
• NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial — Stopped early
• Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) — Completed